ArticlePDF Available

Abstract and Figures

The primary goal of this study was to adapt Berger et al.’s (2001) HIV Stigma Scale in Spain, using Bunn et al.’s (2007) version. A second goal assessed whether the four-factor structure of the adapted scale could be explained by two higher-order dimensions, perceived external stigma and internalized stigma. A first qualitative study (N=40 people with HIV, aged 28-59) was used to adapt the items and test content validity. A second quantitative study analyzed construct and criterion validity. In this study participants were 557 people with HIV, aged 18-76.The adapted HIV Stigma Scale for use in Spain (HSSS) showed a good internal consistency and good construct validity. Confirmatory Factor Analyses yielded a first-order, four-factor structure and a higher-order, bidimensional structure with the two expected factors. Negative relations were found between stigma and quality of life, self-efficacy to cope with stigma, degree of HIV status disclosure, and health status.
Content may be subject to copyright.
Adaptation of the HIV Stigma Scale in Spaniards with HIV
Maria José Fuster-RuizdeApodaca
1
, Fernando Molero
1
, Francisco Pablo Holgado
1
and
Silvia Ubillos
2
1
Universidad Nacional de Educación a Distancia, UNED, Spain,
2
Universidad de Burgos, Spain.
This study was supported by the Fundación para la Investigación y Prevención
del Sida en España (FIPSE). Research Grant: 24637/07.
Correspondence concerning this article should be addressed to Maria J. Fuster-
RuizdeApodaca. Universidad Nacional de Educación a Distancia (UNED). Calle Juan
del Rosal 10, E-28040 Madrid (Spain) E-mail: mjfuster@psi.uned.es
Spanish adaptation of the HIV Stigma Scale 2
Abstract
The primary goal of this study was to adapt Berger et al.’s (2001) HIV Stigma Scale in
Spain, using Bunn et al.’s (2007) version. A second goal assessed whether the four-
factor structure of the adapted scale could be explained by two higher-order dimensions,
perceived external stigma and internalized stigma. A first qualitative study (N=40
people with HIV, aged 28-59) was used to adapt the items and test content validity. A
second quantitative study analyzed construct and criterion validity. In this study
participants were 557 people with HIV, aged 18-76.The adapted HIV Stigma Scale for
use in Spain (HSSS) showed a good internal consistency and good construct validity.
Confirmatory Factor Analyses yielded a first-order, four-factor structure and a higher-
order, bidimensional structure with the two expected factors. Negative relations were
found between stigma and quality of life, self-efficacy to cope with stigma, degree of
HIV status disclosure, and health status.
Keywords: HIV, Stigma Scale, adaptation, validity, second-order dimensions, Spain
Spanish adaptation of the HIV Stigma Scale 3
Numerous investigations show that stigma associated with HIV has a negative impact
on diverse variables related to quality of life and psychological well-being (Franke et
al., 2010; Logie & Gadalla, 2009; Steward et al., 2011). The perception of stigma can
also have negative implications for physical health (Obermeyer & Osborn, 2007; Rao,
Kekwaletswe, Hosek, Martínez, & Rodriguez, 2007; Stratchan, Murray, Russo, & Roy-
Byrne, 2007). Stigma and discrimination also influence public health negatively
because they discourage people from being tested voluntarily for HIV and they deter
people with HIV from disclosing their status or even from following a treatment for
their infection (Clum, Chung, & Ellen, 2009; King et al., 2008; UNAIDS, 2002).
The stigma associated with HIV is a complex construct that includes diverse
categories and dimensions. One traditional classification divides it into two categories,
enacted and internalized stigma (Parker & Aggleton, 2003; Tsutsumi & Izutsu, 2010;
UNAIDS, 2002). In the former, the source of stigma is external (Enacted stigma), and
in the latter, it is internal (Internalized stigma). More recently, Bos, Pryor, Reeder, and
Stutterheim (2013) pointed out that public stigma (common knowledge that a certain
social attribute is devaluated) affects the self in three ways: (a) through enacted stigma
(perceived negative treatment of the stigmatized people), (b) through felt stigma
(experience or anticipation of the stigmatization), and (c) through internalized stigma
(reduction of self-worth of the stigmatized people). This differentiation is important
because different types of stigma as such constitute sources of stigma that can
differentially affect the stigmatized people.
Stigma and discrimination towards people with HIV are a reality that has been
documented in diverse countries (FIPSE, 2005; Fuster, Molero, Gil de Montes, Vitoria,
& Agirrezabal, 2013; Fuster-RuizdeApodaca et al., 2014; Li et al., 2009; Mahajan et al.,
2008). A recent study of a representative sample of Spanish population showed that an
Spanish adaptation of the HIV Stigma Scale 4
important percentage of them still felt discomfort in the presence of people with HIV
(from 25.8 to 49.8%, depending to the daily life scenario). Moreover, 29% of the
population would avoid the contact with them. Furthermore, around 13% of the
population advocate discriminatory policies, and about 15% blame people with HIV for
having the disease (Fuster-RuizdeApodaca et al., 2014). Concerning internalized
stigma, in recent years, research has revealed its magnitude and relevance in people
with HIV and its important consequences for their psychological well-being and quality
of life (Berger, Ferrans, & Lashley, 2001; Kalichman et al., 2009; Visser, Kershaw,
Makin, & Forsyth, 2008). In a study conducted in Spain in which 221 people with HIV
participated, it was found that the levels of enacted and internalized stigma were a little
higher than the theoretical mean of the scale (Fuster-RuizdeApodaca, Molero, &
Ubillos, in press).
Various instruments have recently been designed to measure HIV-related
stigma. One of the most frequently used and referenced is the Stigma Scale of Berger et
al. (2001). This scale has a reported four-factor structure (Personalized Stigma,
Disclosure Concerns, Negative Self-Image, and Concern with Public Attitudes about
People with HIV). Berger et al.s Stigma Scale has the advantage of being well-
validated in several settings and used fairly extensively in many studies and countries.
(In the table presented as Annex 1, the studies that validated this scale can be consulted
along with the main psychometric properties and validation data of these studies).
Of the four factors of Berger et als. (2001) scale, two of them (Personalized
Stigma and Concern with Public Attitudes) measure perceived stigma expressed by
others (experiences with enacted stigma and felt stigma). For the other two factors
(Disclosure Concerns and Negative Self-Image), the source of the stigma is the person
with HIV, in other words, external and internal source, respectively. Thus, according to
Spanish adaptation of the HIV Stigma Scale 5
the distinction proposed in the literature, these four factors could be included within two
more general dimensions, perceived external stigma (enacted and felt stigma), and
internalized stigma. However, some authors (Kalichman et al., 2009) noted that Berger
et al.s scale does not include items that are sufficiently representative of stigma
internalization, and, therefore, they developed a specific measure of internalized stigma.
To our knowledge, no studies have been conducted to analyze a possible second-order
bidimensional structure accounting for the two general sources of the perception of
stigma (external and internal) by people with HIV. We hypothesize that this second-
order structure could be achieved by adapting items from an internal source to
adequately measure internalized stigma. This proposal could be useful to measure both
sources of stigma with the same scale and to analyze their effects on people with HIV.
This analysis could contribute to designing interventions to reduce the problem of
public stigma and to enable people with HIV to better cope with the problem.
This investigation had two goals: The primary goal was to adapt the Stigma
Scale (Berger et al., 2001) with two aims: to be able to adequately measure internalized
stigma, and for its use in Spain. The second goal was to analyze whether the factor
structure of the adapted scale could be explained by two new higher order dimensions
related to perceived external (enacted and felt stigma) and internalized stigma.
Method
This research was conducted during a two-year interval (2008 and 2009) and it is part of
a more extensive investigation (Fuster, 2011), consisting of three studies involving a
total sample of 687 people with HIV. The research described here involved the first two
studies of the investigation (Fuster, 2011). The first study, a qualitative one, was used to
adapt the items of the Stigma Scale reduced and refined by Bunn et al. (2007), in order
to obtain evidence of content validity. The second study, quantitative and cross-
Spanish adaptation of the HIV Stigma Scale 6
sectional, was conducted to obtain evidence of construct and criterion validity of the
adapted scale.
Participants
A total sample of 597 people participated in the investigation. The inclusion criteria
were: positive HIV diagnosis, being over 18 years of age, and not having any severe
psychiatric or cognitive disorder.
In the first study, 40 people with HIV were interviewed. One half of them were
men and one half were women. Their ages ranged from 28 to 59 years (M = 42.98, SD =
5.95). Most of them (57.5%) were working, 40% had finished high school, and 30% had
attended elementary school. Regarding health characteristics, 60% of the interviewees
had acquired the infection through unprotected sexual relations, 92.5% were undergoing
antiretroviral treatment, and 82.5% had satisfactory immunological and virological
status.
In the second study, there were 557 participants with HIV, aged 18-76. Most of
them were men and more than half of them were heterosexual, single, and unemployed.
On average, the participants had been infected by HIV for more than ten years, and
more than half of them had acquired the infection through sexual contact. Medically,
they were currently taking antiretroviral therapy and had a good immunological and
virological status (Table 1).
Insert Table 1 about here.
Instruments
The instrument employed in the qualitative study was a semistructured interview with
open questions. The interview was comprised of six blocks of questions. For the
purpose of this investigationthe adaptation of the Stigma Scale (Bunn et al., 2007)
itemswe used the discourse categories corresponding to the following questions: (a)
Spanish adaptation of the HIV Stigma Scale 7
main problems perceived of the collective of people with HIV (Can you tell me what
you think are the main problems or difficulties faced by people with HIV in our
society?), main perceived personal problems and concerns (What are the main problems
or difficulties that you must face in your daily life because of your condition of being a
person with HIV?), thoughts, and feelings related to their HIV status (What thoughts
and feelings does a person with HIV provoke in you?); (b) perception of stigma and
discrimination (To what extent do you think that stigma and discrimination towards
people with HIV are currently a problem?, Have you ever suffered some kind of
rejection?, Can you tell me what happened?), justification of discrimination (What do
you think are the reasons for stigma?), personal responses to perceived stigma and to
personally experienced stigma (Could you tell me about your feelings, thoughts, and
actions when you suffered rejection?); (c) level of disclosure of serologic status: reasons
and drawbacks (To what extent do you usually disclose to others that you have HIV?,
What are your reasons for disclosing it?, And for concealing it?).
To measure stigma and the variables used to assess the criterion validity in the
quantitative study, the following instruments were used:
Stigma Scale. We used the revised and refined adapted version of Bunn et al.
(2007). These authors re-analyzed the psychometric properties of Berger et al.’s (2001)
scale. The scale is rated on a 4-point Likert-type response format (1 = strongly
disagree, 4 = strongly agree). This scale showed a good internal consistency and
evidences of construct and criterion validity (Appendix 1).
The scale was translated following the International Test Commission (2006)
guidelines for the translation and adaptation of questionnaires. For this purpose,
backward translation was performed: The scale was translated independently from
English to Spanish by two expert translators, who were familiar with the basic
Spanish adaptation of the HIV Stigma Scale 8
psychometric aspects of item construction. The research team assessed the translations,
reaching a consensus on the final items. After translation, the scale was adapted to the
reality of people with HIV in Spain. For this purpose, a team of seven experts reviewed
it to verify that the items coincided with the discourse categories found in the qualitative
study. As a result of this analysis, some new items were included and others were
eliminated or their wording was changed. The final, 30-item translated version was
reviewed individually by 15 people with HIV in order to guarantee apparent validity.
Then, all the items were re-translated into English by a bilingual person who was blind
to the prior translation process. The items of this translation were compared with the
original items to verify that there were no important differences.
Quality of Life Questionnaire (Ruiz and Baca, 1993). The scale has a 5-point
self-report response format, with higher scores indicating better health status (1 = Not at
all, 5 = Very much). This instrument has shown evidences of good internal consistency,
temporal stability, sensitivity to significant clinical changes, and content and construct
validity (internal structure, concurrent and discriminant validity) in Spanish adult
population. Thus, the Cronbach alpha coefficient across studies ranged from α = .82 to α
= .94. The questionnaire also showed test-retest reliability, with levels of stability
ranging from r = .77 to r =.97. The correlations among quality of life and the criterion
variables ranged from r = -.33 and r = -.73. Three of the four factors of this
questionnaire were used for this investigation: Social Support, General Satisfaction, and
Physical and Psychological Well-being. The Cronbach alpha coefficients for these
factors in this study were α = 85, α = .86, and α = .82, respectively.
Perceived Self-Efficacy to Cope with Stigma Scale (Fuster, 2011). Based on the self-
efficacy literature, we used four items that are rated on a 4-point Likert-type response
format, with higher scores indicating a higher perceived self-efficacy. The construct of
Spanish adaptation of the HIV Stigma Scale 9
this scale was also validated by means of confirmatory factor analysis, and the results
showed a first-order one-dimensional structure (Fuster, 2011). The internal consistency
of the scale was satisfactory (α = .78).
Degree of HIV status disclosure. Based on the research of Stratchan et al. (2007), we
used one item rated on a 5-point Likert-type response format with higher scores
indicating more HIV status disclosure (1 = Never disclose, 5 = Always disclose).
Health status. We included questions related to years living with HIV, lymphocyte CD4
count, viral load copies, and suffering from AIDS-related opportunistic infection.
Procedure
During their consultations or when attending to diverse services, professionals from
health centers explained the goals of the study to the participants, requesting their
participation and obtaining their informed consent. In the case of the qualitative study,
participants were requested to take part in an in-depth interview, and, if they agreed, the
researcher-interviewer contacted them to schedule a meeting. At the beginning of the
interview, permission was requested to audio-tape the interview, informing the
participants of its subsequent transcription and of the confidentiality of the data. In the
case of the quantitative study, the professionals handed out the anonymous and self-
administered questionnaire to the participants to complete while in the waiting-rooms of
the centers and subsequently return to the professionals.
Ethical approval and permission to conduct the research was granted by the non-
governmental organizations and hospitals involved in the study. All the procedures of
this study followed the 1964 Helsinki declaration (revised in 1996), as well as the
guidelines for good clinical practice.
Data Analysis
Content Validity
Spanish adaptation of the HIV Stigma Scale 10
To analyze the qualitative data, content analysis of the interviews was conducted by a
team of seven experienced investigators. The narrations of the interviews were
categorized, mainly inductively and according to the topic and the conceptual areas
provided by the interview as a whole. Next, the data were coded by counting the
frequencies of the references in each category of the narration. Each section of the
interview was categorized and coded by two of the seven researchers of the study. Inter-
rater agreement of the coding of each pair of researchers was applied to study the
reliability of the codifications. Inconsistencies were resolved by consensus. The analysis
yielded substantial reliability (Cohens κ = .77, SD = .10, statistic value range from .62
to 1).
Validation of the internal structure of the adaptation of HIV Stigma Scale for use with
Spaniards (HSSS)
First, we conducted first-order confirmatory factor analysis (CFA) to assess the fit of
the adapted questionnaire to the factor structure proposed by the authors of the original
scale (model 2) (Berger et al., 2001; Bunn et al., 2007). Next, to address the second goal
of this investigation, second-order CFA was performed to determine whether the four
first-order factors could be explained by means of two new dimensions or latent factors
(model 1). The new proposed dimensions were Perceived External Stigma, which would
include Personalized Stigma and Concern with Public Attitudes, and Internalized
Stigma, which would include Disclosure Concerns and Negative Self-image. Finally, in
order to compare the model fit to the proposed structure (four first-order factors and two
second-order factors), we tested two alternative models. The first one assessed the fit of
the adapted questionnaire to two first-order factors (Perceived External Stigma and
Internalized Stigma) (model 3). The second one assessed its fit to four first-order factors
and one second-order factor (model 4). We compared the change of the fit between
Spanish adaptation of the HIV Stigma Scale 11
these models and our proposed model (four first-order factors and two second-order
factors).
The robust unweighted least square method was used, as the factors of the scale did not
meet the assumption of normality. To determine goodness of fit, the following indexes
were employed: the Satorra-Bentler chi square, the chi-square-df ratio, the goodness of
fit index (GFI), the adjusted goodness of fit index (AGFI), the root mean square residual
(RMR), the standardized root mean square residual (RMSEA), the comparative fit index
(CFI), the normed fit index (NFI), the nonnormed fit index (NNFI), the incremental fit
index (IFI), and the consistent Akaike information criterion (CAIC).
Criterion validity
Next, we analyzed the criterion validity of the adapted version of the Stigma Scale. For
this purpose, we analyzed, using Pearson`s correlation, the relation between the stigma
dimensions and the following variables related to well-being: (a) the total score of
participants quality of life and each one of its dimensions (Social Support, Life
Satisfaction, and Physical and Psychological Well-being), (b) their perceived self-
efficacy to cope with stigma, and (c) the degree of HIV status disclosure. In accordance
with the literature (Greeff et al., 2010; Holzemer et al., 2007; Fuster-RuizdeApodaca et
al., in press; Logie &Gadalla, 2009), we expect a negative relation between stigma
dimensions and these variables. Finally, we analyzed whether there were differences in
health-related variables as a function of participant’s perceived external and internalized
stigma. We expected poorer physical health in individuals with higher levels of stigma
perception (Logie & Gadalla, 2009).
The PRELIS and LISREL 8.7 programs were used for the CFAs, and, for the
remaining analyses, SPSS 15.
Results
Spanish adaptation of the HIV Stigma Scale 12
Review and Adaptation of the Stigma Scale Items
First, we compared the translation of the scale items with the analyzed discourses of the
people with HIV in those sections of the interview from the qualitative study
corresponding to the topic of this study. A summary of the main categories and their
frequencies can be seen in Table 2. Next, the following modifications were carried out
on Bunn et al.s (2007) revised and reduced version of the HIV Stigma Scale. Items 28,
38, and 39, all belonging to the factor Personalized Stigma, were eliminated. There were
two reasons for these eliminations. The first was to reduce the scale, because this factor
contained the most items, and the items that were eliminated loaded on three factors of
Berger et al.s (2001) original scale. The second reason was that, after translation, the
content of the items was less representative of the reactions of the Spanish population
towards people with HIV than the rest of the items of this factor. Additionally, item 14
was also eliminated, and items 8, 10, and 12 were reworded because their original
wording contained statements and terms that generated rejection or distress or did not
coincide with Spanish reality. Finally, items 15 and 23 were eliminated from the factor
Negative Self-image, and four new items were added to this factor (items 11, 13, 14,
and 18). These new items contained potential attitudes or emotions derived from stigma
internalization that were more representative of the reality of people with HIV in Spain
because they had appeared in the participants discourse in the qualitative study, and
they were not included in the items of the original scale. These items referred to the
justification of stigma, the fear of infecting other people, self-exclusion from affective-
sexual life for fear of transmitting HIV, and the feeling of deserving punishment for
having the infection (see Table 2). The final scale comprised 30 items, and this was
administered to the 557 participants in the second study. The items that comprised the
questionnaire are shown in the Appendix 2.
Spanish adaptation of the HIV Stigma Scale 13
Insert Table 2 about here.
Construct validity
The results of the first-order CFA confirmed the model proposed by the authors (model
2) (Berger et al., 2001). The results showed an acceptable fit of the model to the data
(table 3). As shown in Figure 1, most of the standardized loadings were near or higher
than 0.5, the level considered adequate (Green, 1978). The results of the covariances
among the factors are presented in Table 4.
Insert Figure 1 about here.
Next, second-order CFA was performed. The model confirmed the four first-
order factors found and two second-order factors (model 1). These were Perceived
External Stigma (on which loaded Personalized Stigma and Concern with Public
Attitudes) and Internalized Stigma (which grouped Disclosure Concerns and Negative
Self-image). The model presented an acceptable fit to the data (table 3). Figure 2 shows
the model with the standardized parameters. All the parameters of the model were
statistically significant (p < .05) and the standardized coefficients generally presented
high values although they were moderate in some cases. Likewise, a high correlation
was observed between the second-order dimensions (ϕ = .83).
Insert Figure 2 about here.
Finally, we compare the fit of the different proposed alternative models. As
shown in Table 3, the proposed second-order model (model 1) showed a better RMSEA
value than the model with four first-order factors (model 2). In addition, the change in
chi-square was significant and the fit was the most parsimonious. Also, this proposed
second-order model presented a better fit than the alternative model that confirmed that
the two proposed dimensions of stigma - Perceived External Stigma and Internalized
Stigma -could be explained by two first-order factors (model 3). Finally, we found no
Spanish adaptation of the HIV Stigma Scale 14
differences in chi-square compared with the alternative model with a single second-
order factor (model 4). However, some fit indices were somewhat better (RMR, AGFI,
and CFI) in the model with two second-order factors.
Insert Table 3 about here
Internal consistency
Table 4 shows that the dimensions with the highest internal consistency were
Personalized Stigma and Disclosure Concerns, whereas Negative Self-image and
Concern with Public Attitudes had somewhat lower, albeit good, internal consistency.
The internal consistency of the two second-order dimensions, was also high.
Criterion validity
As can be seen in Table 4, we found negative correlations between the dimensions of
stigma and the target variables related to well-being. Firstly, both the total score on
Quality of Life and on each one of its dimensionsSocial Support, Life Satisfaction,
and Physical and Psychological Well-beinghad negative relationships with the
diverse factors of the Stigma Scale. The highest negative relationship was with the
second-order dimension, Perceived External Stigma. Regarding the first-order factors,
Personalized Stigma and Negative Self-image had higher negative relations with total
Quality of Life and its dimensions than the other two factors (Disclosure Concerns and
Concern with Public Attitudes of Rejection). Furthermore, we found negative
correlations between all the stigma dimensions and perceived self-efficacy to cope with
stigma. In this case, the highest correlation was found between self-efficacy and
internalized stigma. Moreover, the same patterns of correlations were found between
stigma dimensions and the degree of disclosure of HIV-positive status. However, in this
case, the correlation between disclosure and the first-order factor Personalized Stigma
was nonsignificant.
Spanish adaptation of the HIV Stigma Scale 15
Finally, some differences as a function of the participant’s physical health were
found. Those who had suffered AIDS-related opportunistic infections had a higher score
in the Perceived External Stigma dimension (M = 2.66, SD = .68) than those who had
not suffered them (M = 2.48, SD = .65), t (493) = 3.02, p = .003, d = 0.26. We found no
significant differences in the scores of the Internalized Stigma dimension.
Stigma Scale Scores
The scores of the total Stigma Scale and its factors were calculated according to the
method described by Berger et al. (2001), adding the values corresponding to each
response, such that higher scores are related to higher perceived stigma in its diverse
dimensions. The scores of factors Personalized Stigma and Negative Self-image were
slightly below the theoretical mean of the possible score for these factors. The mean
scores of the factors of Concern with Public Attitudes of Rejection and Disclosure
Concerns were high, exceeding the theoretical mean. With regard to the second-order
dimensions, we observed that the Internalized Stigma score was slightly higher than the
theoretical mean of the scale, whereas the Perceived External Stigma score was lower
than that mean (see Table 4).
Insert Table 4 about here.
Discussion
As a result of this investigation, we have a version of the Stigma Scale (Berger et al.,
2001; Bunn et al., 2007) adapted to a large sample of people with HIV in Spain. Thus,
an outcome of this adaptation study, a questionnaire that measures two important
dimensions of stigma (perceived external and internalized stigma) suffered by people
with HIV is available. These results indicate that the 30-item version proposed shows
diverse evidence of validity content, apparent, construct, criterion validity and
therefore has good psychometric properties for use with Spaniards.
Spanish adaptation of the HIV Stigma Scale 16
Regarding validity, the adaptation was performed on the basis of the results of a
broad qualitative study, which allowed us to know at first hand the relevant issues about
the perception of stigma and discrimination by Spaniards with HIV. Thus, both the
original items retained and those included or modified are representative of Spaniards
experience of stigma (both perceived external stigma and internalized stigma).
Therefore, these items provide evidence of content validity and allow the measurement
of both sources of stigma with the same instrument. Moreover, a small study of
comprehension and appraisal by people with HIV was conducted, which allowed us to
adjust the drafting and translation of the items to the reality of their situation and to the
idiomatic language used in Spain. This provides evidence of apparent validity.
Second, evidence of construct validity was provided, both for internal (internal
structure) and external aspects (criterion validity). Concerning the internal structure of
the scale, this study has confirmed the four-factor structure proposed by its original
authors (Berger et al., 2001). From the results, we conclude that the stigma perceived by
people with HIV corresponds to a multidimensional model of four first-order factors
that are related to each other, although with different contents.
However, this study has also gone one step further, showing that these four
factors can be grouped into and summarized as two latent second-order dimensions,
perceived external and internalized stigma. This factorial structure had the best and
more parsimonious fit. Furthermore, this structure responds to the division identified in
the literature and by international organizations about the types of stigma perceived by
people with HIV (Bos et al., 2013; Herek et al., 2013; Parker & Aggleton, 2003;
Tsutusmi & Izutsu, 2010; UNAIDS, 2002). Thus, a second-order dimension related to
diverse situations of rejection that people with HIV perceive from an external source,
the majority group, was found. This dimension, perceived external stigma, includes
Spanish adaptation of the HIV Stigma Scale 17
personally experienced situations of rejection or discrimination, and also the rejection
that people with HIV perceive directed towards the HIV community in general.
Therefore, this dimension includes the concepts of enacted and felt stigma, as used by
Herek et al. (2013). The second dimension, internalized stigma, includes feelings and
concerns derived from the internalization of the negative attitudes of society and
expressed in this scale through negative self-image and concerns about serostatus
disclosure. Thus, this dimension is similar to the concept of self-stigma used both by
Boss et al. (2013) and by Herek et al. (2013).
Regarding this second-order factorial structure, it is important to note that the
relation found between the two second-order dimensions is high, and no significant
differences were found with respect to a single second-order factor. However, this could
be because both are dimensions of the same social problem, the stigma suffered by
people with HIV. In our opinion, the evidence of the content validity (based on of the
theory of stigma and a qualitative study) and the differences in the size of the
correlations of the two second-order dimensions of stigma with the criterion variables
indicate that they are two different dimensions. The differentiation and study of these
two sources of stigma is important because they allow us to better understand their
implications in people with HIV.
Evidence of criterion validity was also provided. Firstly, we found a negative
relation of all the dimensions of stigma with the dimensions of quality of life and self-
efficacy to cope with stigma and the degree of disclosure of HIV-positive status.
With regard to the relations of the first-order factors with quality of life, the
lowest correlations were found in the factors Disclosure Concerns and Concern with
Public Attitudes. With regard to the second-order dimensions, Perceived External
Stigma was the dimension with the strongest association. These findings are consistent
Spanish adaptation of the HIV Stigma Scale 18
with other investigations (Holzemer et al., 2007). Thus, Franke et al. (2010) found that
the perception of stigma is negatively related to quality of life. Although these authors
used a different measure of quality of life, they also found that the factors with the
lowest correlations were Disclosure Concerns and Concern with Public Attitudes.
Previously, both Berger et al. (2001) and Bunn et al. (2007) had reported that high
scores on the Stigma Scale correlated negatively with an important component of
psychological well-being (self-esteem). In the study of Bunn et al., the lowest relation
was also found with the factor Disclosure Concerns. There are several possible
explanations for these findings. Regarding the factor Concern with Public Attitudes,
perceiving stigma and discrimination towards people with HIV does not necessarily
imply that the person has suffered it in the personal sphere. This would have a more
negative impact on quality of life. In fact, research of discrimination in diverse socially
disadvantaged groups concludes that there is a discrepancy between personal and group
discrimination. This discrepancy may be due to the benefits for well-being of denying
personal discrimination (Taylor, Wright, & Porter, 1994). With regard to the factor
Disclosure Concerns, other studies have shown that its impact on quality of life could
derive through the mediation of other variables, such as self-efficacy or coping
strategies (Fuster, 2011).
Regarding the negative correlations of the dimensions of stigma with perceived
self-efficacy to cope with stigma, we found that the strongest correlation was with
internalized stigma. This result is consistent with research showing the negative effects
of internalized stigma not only on the well-being of people with HIV but also on their
capacity to seek social support or to cope with stigma (Fuster-RuizdeApodaca et al., in
press; Herek, Saha, & Burack, 2013; Stutterheim et al., 2011; Visser et al., 2008).
Furthermore, some authors have indicated that, as internalized stigma is a negative
Spanish adaptation of the HIV Stigma Scale 19
attitude towards an aspect of oneself, this constitutes some sort of specific domain of
low self-esteem (Herek et al., 2013).
The negative correlations found between the dimensions of stigma and the
degree of disclosure of HIV-positive status are also consistent with the literature (Logie
& Gadalla, 2009). In this case, internalized stigma had also the strongest negative
correlation. In fact, disclosure concerns are a relevant dimension of internalized stigma.
Finally, we found some relation between stigma dimensions and the participants’
psychical health. Those who had suffered opportunistic infections related to AIDS had a
higher punctuation in the Perceived External Stigma dimension. This result is also
consistent with the literature showing the negative effects of stigma on physical health
(Logie & Gadalla, 2009; Stratchan et al., 2007).
The internal consistency found for the total scale and for the factors is good. The
coefficients are lower than those of the original scale (Berger et al. 2001), which may be
related to the lower number of items in this adapted version. However, compared to the
reduced version of Franke et al. (2010), similar and even higher coefficients were found
in some factors, such as Disclosure Concerns.
Finally, the results of the scale scores show that the most relevant concerns are
related to public attitudes about people with HIV and to disclosure. This same result
was found by Franke et al. (2010) in the version of the scale validated for Peruvians. In
other studies with the scale, personalized stigma appeared as one of the most relevant
sources of stigma for the interviewees (Bunn et al., 2007). The coincidence of the
results found with the scale of Franke et al. (2010) and the differences with the other
studies carried out in an American population indicate that the realities experienced by
people with HIV in varied cultural settings may be very different. In Spain,
approximately 80% of the people with HIV conceal their condition to some extent
Spanish adaptation of the HIV Stigma Scale 20
(Agirrezabal, Fuster & Valencia, 2009; Fuster, 2011). This high rate of concealment
could imply, on the one hand, less personal exposure to stigma and discrimination or, on
the other hand, cognitive overload related to the constant concern about secret thoughts
(Quinn, 2006). In fact, in this study, the stigma dimension with the highest score in our
participants was that of Internalized Stigma. It does not, therefore, seem that the
problem of stigma in Spain derives from third persons but instead that the main source
of stigma is internal; that is, the people with HIV. This result had been found in other
studies (Visser et al., 2008).
The results of this study have important implications, as they clear the way to the
possibility of performing two strategies for the assessment of stigma perceived by
people with HIV. The use of first- or second-order scores will depend on the
researchers interests and the purpose of the measure. Assessment through the second-
order dimensions could provide a continued appraisal of the sources of stigma in our
society, clarifying the intensity and the direction and dimension of the response. In this
sense, for example, through the second-order dimensions, those in charge of designing
policies and allocating resources to address the topic of this study could determine the
kind of interventions that are needed. On the other hand, four-dimensional assessment,
by explaining more response variability and, as a result, gaining discriminative capacity,
might detect more particular problems with stigma and, thereby, contribute to designing
more specific interventions as a function of the people involved.
Limitations and proposals for improvement
Despite the fact that a strong point of this study was the large sample size, it has some
limitations. One of them is that the HIV community is heterogeneous, so future studies
are needed to analyze scale invariance across sexes and as a function of other
sociodemographic or relevant health characteristics. This is a central issue in the field of
Spanish adaptation of the HIV Stigma Scale 21
measurement and one that would allow generalization of the model (Vandenberg &
Lance, 2000). Furthermore, it would be necessary to conduct crossed validation of the
results in future studies.
Finally, it is important to underline that in this research, we adapted the Stigma
Scale (Berger et al., 2001). This adaptation has allowed us to measure two major
sources of stigma with the same scale. However, given that changes have been made in
some items, this will affect cross-cultural comparisons.
Spanish adaptation of the HIV Stigma Scale 22
References
Agirrezabal, A., Fuster, M. J., & Valencia, J. (2009). Informe FIPSE. Integración
laboral de las personas con VIH. Estudio sobre la identificación de las
necesidades laborales y la actitud empresarial [Job integration of people with
HIV. Study of the identification of job needs and company attitude]. Madrid:
FIPSE.
Berger, B. E., Ferrans, C. E., & Lashley, F. R. (2001). Measuring stigma in people with
HIV: Psychometric assessment of the HIV Stigma Scale. Research in Nursing
and Health, 24, 518-529. http://dx.doi.org/10.1002/nur.10011
Bezabhe, W. M., Peterson, G. M., Bereznicki, L., Chalmers, L., & Gee, P. (2013).
Adherence to antiretroviral drug therapy in adult patients who are HIV-positive
in Northwest Ethiopia: a study protocol. BMJ open, 3, e003559.
http://dx.doi.org/10.1136/bmjopen-2013-003559
Bos, A. E., Pryor, J. B., Reeder, G. D., & Stutterheim, S. E. (2013). Stigma: Advances
in theory and research. Basic and Applied Social Psychology, 35, 1-9.
http://dx.doi.org/10.1080/01973533.2012.746147
Bunn, J. Y., Solomon, S. E., Millar, C., & Forehand, R. (2007). Measurement of stigma
in people with HIV: A re-examination of the HIV Stigma Scale. AIDS Education
and Prevention, 19, 198-208.
Choi, P., Kavasery, R., Desai, M. M., Govindasamy, S., Kamarulzaman, A., & Altice,
F. L. (2010). Prevalence and correlates of community re-entry challenges faced
by HIV-infected male prisoners in Malaysia. International journal of STD &
AIDS, 21, 416-423. http://dx.doi.org/10.1258/ijsa.2009.009180
Spanish adaptation of the HIV Stigma Scale 23
Clum, G., Chung, S. E., Ellen, J. M., & Adolescent Medicine Trials Network for
HIV/AIDS Intervention. (2009). Mediators of HIV-related stigma and risk behavior in
HIV infected young women. AIDS Care, 21, 1455-1462.
http://dx.doi.org/10.1080/09540120902883069
FIPSE. (2005). Informe FIPSE sobre discriminación arbitraria de las personas que
viven con VIH o SIDA [FIPSE report on the arbitrary discrimination of people
living with HIV or AIDS]. Madrid: FIPSE.
Franke, M. F., Muñoz, M., Finnegan, K., Zeladita, J., Sebastian, J. L., Bayona. J. N., &
Shin, S. S. (2010). Validation and abbreviation of an HIV Stigma Scale in an
adult Spanish-speaking population in urban Peru. AIDS and Behavior, 14, 189-
199. http://dx.doi.org/10.1007/s10461-008-9474-1
Fuster, M. J. (2011). La percepción del estigma en las personas con VIH: sus efectos y
formas de afrontamiento. [The perception of stigma in people with HIV: Its
effects and ways of coping] (Dissertation). Retrieved from http://e-
spacio.uned.es/fez/eserv.php?pid=tesisuned:Psicologia-
MJfuster&dsID=Documento.pdf.
Fuster, M. J., Molero, F., Gil de Montes, L., Vitoria, A., & Agirrezabal, A. (2013). HIV-
and AIDS-related stigma: Psychosocial aspects in a representative Spanish
sample. Spanish Journal of Psychology, 16, E30.
http://dx.doi.org/10.1017/sjp.2013.52
Fuster-RuizdeApodaca, M. J., Molero, F., Gil de Montes, L., Agirrezabal, A., Toledo,
J., Jaén, A. and the Spanish Group for the Study of HIV-Related Stigma. (2014).
Evolution of HIV-related stigma in Spain between 2008 and 2012. AIDS Care,
(ahead-of-print), 1-5. http://dx.doi.org/10.1080/09540121.2014.906557
Spanish adaptation of the HIV Stigma Scale 24
Fuster-RuizdeApodaca, M. J., Molero, F., y Ubillos, S. (in press). Assessment of an
intervention to reduce the impact of stigma on people with HIV, enabling them
to cope with it. Anales de Psicología.
Greeff, M., Uys, L. R., Wantland, D., Makoae, L., Chirwa, M., Dlanini, P.,…Holzemer,
W. L. (2010). Perceived HIV stigma and life satisfaction among persons living
with HIV infection in five African countries: A longitudinal study. International
Journal of Nursing Studies, 47, 475486.
http://dx.doi.org/10.1016/j.ijnurstu.2009.09.008
Green, P. (1978). Analyzing multivariate data. Hinsdale, IL: Dryden Press.
Herek G. (2007). Confronting sexual stigma and prejudice: Theory and practice.
Journal of Social Issues, 63, 905-925. http://dx.doi.org/10.1111/j.1540-
4560.2007.00544.x
Herek, G., Saha, S. y Burack, J. (2013). Stigma and psychological distress in people
with HIV/AIDS. Basic and Applied Social Psychology, 35, 41-54.
http://dx.doi.org/10.1080/01973533.2012.746606
Holzemer, W. L., Uys, L. R., Chirwa, M. L., Greeff, M., Makoae, L. N., Kohi, T. W.,
Durrheim, K. (2007). Validation of the HIV/AIDS Stigma InstrumentPLWA
(HASI-P), AIDS Care, 19, 1002-1012.
http://dx.doi.org/10.1080/09540120701245999
Jeyaseelan, L., Kumar, S., Mohanraj, R., Rebekah, G., Rao, D., & Manhart, L. (2013).
Assessing HIV/AIDS Stigma in South India: Validation and abridgment of the
Berger HIV Stigma Scale. AIDS and Behavior, 17, 434-443.
http://dx.doi.org/10.1007/s10461-011-0128-3
Jimenez, J. C., Puig, M., Ramos, J. C., Morales, M., Asencio, G., Sala, A. C., ... &
Zorrilla, C. (2010). Measuring HIV felt stigma: a culturally adapted scale
Spanish adaptation of the HIV Stigma Scale 25
targeting PLWHA in Puerto Rico. AIDS care, 22, 1314-1322.
http://dx.doi.org/10.1080/09540121003758481
Kalichman, S. C., Simbayi, L. C., Cloete, A., Mthembu, P. P., Mkhonta, R. N., &
Ginindza, T. (2009). Measuring AIDS stigmas in people living with HIV/AIDS:
The Internalized AIDS-related Stigma Scale. AIDS Care, 21, 87-93.
http://dx.doi.org/10.1080/09540120802032627
King, R., Katuntu, D., Lifshay, J., Packel, L., Batamwita, R., Nakayiwa, S.,, Bunnell,
R. (2008). Processes and outcomes of HIV serostatus disclosure to sexual
partners among people living with HIV in Uganda. AIDS and Behavior, 12, 232-
243. http://dx.doi.org/10.1007/s10461-007-9307-7
Li, L., Liang, L., Wu, Z., Lin, C., & Wen, Y. (2009). Individual attitudes and perceived
social norms: Reports on HIV/AIDS-related stigma among service providers in
China. International Journal of Psychology, 44, 443-450.
http://dx.doi.org/10.1080/00207590802644774
Logie, C., & Gadalla, T. M (2009). Meta-analysis of health and demographic correlates
of stigma towards people living with HIV. AIDS Care, 21, 742-53.
http://dx.doi.org/10.1080/09540120802511877
Mahajan, A. P., Sayles, J. N., Patel, V. A., Remien, R. H., Sawires, S. R., Ortiz, D. J.,
Coates, T. J. (2008). Stigma in the HIV/AIDS epidemic: A review of the
literature and recommendations for the way forward. AIDS, 22, S67-S79.
http://dx.doi.org/10.1097/01.aids.0000327438.13291.62
Massicotte, A.C.R. (2010). A comparative analysis of quality of life and stigma
experienced by people living with HIV receiving antiretroviral therapy in a
home-based care project in Malema and Ribaue districts, Mozambique.
Spanish adaptation of the HIV Stigma Scale 26
Dissertation (Social Behaviour Studies in HIV/AIDS). University of South
Africa.
Miric, M. (2004). Escala para la evaluación del Estigma Sentido El Caribe, varios
idiomas y muchas culturas, unido para combatir el VIH/SIDA [Scale to assess
Felt Stigma El Caribe, various languages and many cultures, united to fight
HIV/AIDS]. Santo Domingo, RD; 5-7 March, 2004. Retrieved from
http://soft2.uasd.edu.do/IPSU/Documentos%20y%20PDF/Miric%20Escala%20p
ara%20la%20evaluaci%C3%B3n%20del%20Estigma.pdf.
Obermeyer, C. M., & Osborn, M. (2007). The utilization of testing and counseling of
HIV: A review of the social and behavioral evidence. American Journal of
Public Health, 97, 1762-1774. http://dx.doi.org/10.2105/AJPH.2006.096263
Parker, R., & Aggleton, P. (2003). HIV and AIDS-related stigma and discrimination: A
conceptual framework and implications for action. Social Science & Medicine,
57, 13-24. http://dx.doi.org/10.1016/S0277-9536(02)00304-0
Quinn, D. M. (2006). Concealable versus conspicuous stigmatized identities. In S.
Levin, & C. van Laar, (Eds.), Stigma and group inequality: Social psychological
perspectives (pp. 83-103). Mahwah, NJ: Erlbaum.
Rao, D., Kekwaletswe, T. C., Hosek, S., Martinez, J., & Rodriguez, F. (2007). Stigma
and social barriers to medication adherence with urban youth living with HIV.
AIDS Care, 19, 28-33. http://dx.doi.org/10.1080/09540120600652303
Ruiz, M. A., & Baca, E. (1993). Design and validation of the Quality of Life
Questionnaire (Cuestionario de Calidad de Vida, CCV): A generic health-related
quality of life instrument [Un instrument genérico de calidad de vida]. European
Journal of Psychological Assessment, 9, 19-32.
Spanish adaptation of the HIV Stigma Scale 27
Sarna, A., Luchters, S., Geibel, S., Chersich, M. F., Munyao, P., Kaai, S., ... &
Rutenberg, N. (2008). Short-and long-term efficacy of modified directly
observed antiretroviral treatment in Mombasa, Kenya: a randomized trial. JAIDS
Journal of Acquired Immune Deficiency Syndromes, 48, 611-619.
http://dx.doi.org/10.1097/QAI.0b013e3181806bf1
Steward, W. T., Chandy, S., Singh, G., Panicker, S. T., Osmand, T. A., Heylen E., &
Ekstrand, M. L. (2011). Depression is not an inevitable outcome of disclosure
avoidance: HIV stigma and mental health in a cohort of HIV-infected individuals
from southern India. Psychology, Health and Medicine, 16, 74-85.
http://dx.doi.org/10.1080/13548506.2010.521568
Taylor, D. M., Wright, S. C. & Porter, L. E. (1994). Dimensions of perceived
discrimination: The personal/group discrimination discrepancy. In M.P. Zanna &
J.M. Olson (Eds.), The psychology of prejudice: The Ontario Symposium (Vol. 7,
pp. 233-235). Mahwah, NJ: Erlbaum.
The International Test Commission. (2006). International guidelines on computer based
and internet delivered testing. International Journal of Testing, 6, 143-171.
Tsutsumi, A., & Izutsu, T. (2010). Quality of life and stigma. In R. Preedy & R. R.
Watson (Eds.), Handbook of disease burdens and quality of life measures (pp.
3490-3499). New York: Springer.
UNAIDS. (2002). A conceptual framework and basis for action: HIV/AIDS stigma and
discrimination. Retrieved from http://data.unaids.org/publications/IRC-
pub02/jc891-wac_framework_en.pdf
Vandenberg, R. J., & Lance, C. E. (2000). A review and synthesis of the measurement
invariance literature: Suggestions, practices, and recommendations for
Spanish adaptation of the HIV Stigma Scale 28
organizational research. Organizational Research Methods, 3(1), 4-69.
http://dx.doi.org/10.1177/109442810031002
Visser, M. J., Kershaw, T., Makin, J. D., & Forsyth, B. W. C. (2008). Development of
parallel scales to measure HIV-related stigma. AIDS and Behavior, 12, 759-771.
http://dx.doi.org/10.1007/s10461-008-9363-7
Wiklander, M., Rydström, L-L., Ygge, B-M., Navér, L., Wettergren. L, & Eriksson, L.
(2013). Psychometric properties of a short version of the HIV stigma scale,
adapted for children with HIV infection. Health and Quality of Life Outcomes,
11, 195. http://dx.doi.org/10.1186/1477-7525-11-195
Wright, K. Naar-King, S., Lam, P., Templin, T., & Frey, M. (2007). Stigma Scale
Revised: Reliability and Validity of a Brief Measure of Stigma For HIV +
Youth. Journal of Adolescent Health, 40(1), 9698.
http://dx.doi.org/10.1016/j.jadohealth.2006.08.001
Spanish adaptation of the HIV Stigma Scale 29
Table 1. Sociodemographic and clinical characteristics of the 557 participants of the
quantitative study
%
70.8
28
1.3
43.43 ± 8.09
7.1
34.6
41.1
15.1
2
31.4
16.1
45.4
7.1
31.7
9.4
58.9
56.4
33.1
6.1
4.4
57.7
21.3
0.4
20
0.5
13.5 ± 7.6
88.2
557.8 ± 288.7
62.7
Note: Data in percentages unless otherwise stated.
Spanish adaptation of the HIV Stigma Scale 30
Table 2. Categories of the content analysis of the qualitative study and percentages of
people who mention each one (n = 40)
Categories
%
Main problems perceived by the group of people with HIV
Stigma and discrimination
82.5
Concerns related to concealing serology and self-stigmatization
22.5
Main perceived personal concerns and problems
Emotional and cognitive burden derived from concealing HIV
32.5
Concern about disclosing serology to partner
20
Stigma compelled by family and friends
7.5
Limitations of rights and opportunities derived from the stigma
15
Personal experience of stigma
80
Expressions and forms of stigma experienced
Health sphere
42.5
Work setting
12.5
Affective and sexual life
17.5
Physical isolation
12.5
Social isolation
7.5
Derogatory verbal expressions
27.5
Feelings related to internalization of stigma
Feelings of guilt for having HIV
42.5
Feelings of shame for having HIV
40
Feelings of being punished for having HIV
37.5
Fear of transmitting the infection
30
Justification of stigma and discrimination
42.5
Behaviors of self-exclusion derived from the stigma
Avoidance of affective and sexual relations
25
Avoidance of seeking job opportunities
20
Avoidance of physical contact
12.5
Avoidance of social contact
12.5
Avoidance of contact with other people with HIV
12.5
Degree of concealment of serology
High concealment
37.5
Selective disclosure
25
Selective concealing
5
Visibility
32.5
Reasons for concealing serology
Fear of others' rejection
52.5
Protection of significant others from stigma by association
17.5
Forced to or advised by others
10
Protection of significant others from suffering
22.5
Drawbacks of concealing serology
Emotional and cognitive burden of concealing a central identity aspect
45
Social and affective isolation
15
Fear of transmitting the infection
10
Note: Main global categories obtained from the sections of the interview used in the present
investigation. Responses to many of the categories allowed multiple coding.
Spanish adaptation of the HIV Stigma Scale 31
31
Table 3. Fit indexes of the proposed model and the alternative models
RMSEA [90% CI]
RMR
GFI
AGFI
CFI
NFI
NNFI
IFI
CAIC
Satorra-
Bentler χ
2
df
χ
2
(∆df)
1
Model 1.
(four first-order factors and two
second-order factors)
.051 [.046, .056],
.073
.96
.96
.98
.96
.98
.98
1281.71
813. 28
(p= .000)
398
Model 2. (four first-order
factors)
.054 [.050, .059]
.072
.96
.96
.98
.96
.98
.98
1405.33
934.96
(p = .000)
339
121.68 (59)
(p = .000)
Model 3. (two first-order
factors)
.084 [.080, .088]
.091
.94
.94
.95
.93
.94
.95
2141.73
1706.99
(p= .000)
404
893.45 (6)
(p = .000)
Model 4.
(four first-order factors and one
second-order factor)
.051 [.046, .056]
.076
.96
.95
.96
.96
.98
.98
1270.91
816.47
(p= .000)
400
3.19 (2)
(p = .20)
1
Change in chi-square between the proposed model (Model 1) and the rest of the proposed alternative models.
Spanish adaptation of the HIV Stigma Scale 32
32
Table 4. Descriptive statistics, covariances (ϕ) between the factors of the Spanish HIV Stigma Scale and correlations between the factors of the
Spanish HIV Stigma Scale and the criterion variables
Covariances (ϕ)
Pearson’s Correlations (r)
M
SD
Range
scores
Cronbach’
s α
PS
DC
NSI
CPA
Social
Support
Life
Satisfaction
Physical and
Psychological
Well-being
Quality of
Life
Self-
efficacy
HIV
disclosure
PS
16.82
7.03
8-32
.89
1
.50
.57
.59
-.36**
-.33**
-.29**
-.39**
-.30**
-.07
DC
26.32
6.79
9-36
.78
1
.72
.57
-.19**
-.18**
-.16**
-.21**
-.54**
-.54**
NSI
16.73
5.21
8-32
.70
1
.50
-.31**
-.29**
-.27**
-.34**
-.40**
-.30**
CPA
14.87
3.56
5-20
.75
1
-.13**
-.21**
-.19**
-.21**
-.24**
-.16**
PES
29.46
9.23
13-52
.87
-.33**
-.32**
-.28**
-.37**
-.33**
-.13**
IS
43.06
10.44
17-68
.82
-.28**
-.26**
-.24**
-.31**
-.56**
-.49**
HSSS
74.67
17.01
30-120
.88
-.35**
-.34**
-.30**
-.39**
-.50**
-.35**
Note: The scale has a range of 4 points. PS = Personalized Stigma, DC = Disclosure Concerns, NSE = Negative Self-Image, CPA = Concern with Public Attitudes, PES =
Perceived External Stigma, IS = Internalized Stigma. Perceived External Stigma and Internalized Stigma are the dimensions resulting from the second-order CFA. HSSS =
HIV Stigma Scale Spain.
** p < .01.
Spanish adaptation of the HIV Stigma Scale 33
33
Figure 1. First-order confirmatory factor analysis of the adapted HIV Stigma Scale.
Estimation of the robust unweighted least squares.
Spanish adaptation of the HIV Stigma Scale 34
34
Figure 2. Second-order confirmatory factor analysis of the adapted HIV Stigma Scale.
Estimation of the robust unweighted least squares. PS = Personalized Stigma, DC =
Disclosure Concerns, NSI = Negative Self-Image, CPA = Concern with Public
Attitudes.
Spanish adaptation of the HIV Stigma Scale 35
35
Appendix 1
Studies that have made adaptations and validations of the HIV Stigma Scale
Country
Authors and Year
Version
N
Back-translation
Reliability
Internal Validity
External Validity
US (New
England)
Bunn et al., 2007
HSS
1
-32
157 HIV+ (19-64 years)
Original version
HSS-32: .95
Factors: .90 to .97
CFA
8
: Four factors
9
Negative correlation with self-esteem and
positive with stigma consciousness,
discrimination and fear of discovery
India (Tamil
Nadu State)
Jeyaseelan et al.,
2013
HSS-25
250 HIV+ (18-40+
years)
Yes
Tamil
HSS-25: .88
Factors: .88 to .68
(Disclosure: .19)
EFA
10
, CFA: Four
factors
Higher among HIV +
with major depression than among those
without major depression (MDI)
Peru (Lima)
Franke et al., 2010
HSS-21
130 HIV + (IQR
6
: 26
37 years).
Yes
Spanish
HSS-21: .84
Factors: .68 to .84
EFA: Four factors
Negative correlation with QoL (MOS-HIV)
and mental health (MOS-HIV mental
health) and positive with depression
República
Domicana
Miric (2004)
HSS-18
(dummy)
254 HIV+ people (15-
65 years old)
HSS-18: .84
Factors: .83 to .51
EFA: Four factors
Negative correlation with self-esteem, social
support and positive correlation with
depression
Puerto Rico
Jimenez et al., 2010
HFSS
2
-17
106 HIV +
Yes
Spanish
HFSS-17: .91
Factors: .77 to .88
EFA: Four factors
Positive correlation with depression and
sexual abuse
Kenya
(Mombasa)
Sarna et al. (2008)
HSS-16
234 HIV + (M≈37
years)
Swahili
HSS-16: .81
Three factors: DC,
NSI and CPA
9
No information
11
US (Michigan)
Wright et al., 2007
HSS-10
3
48 HIV + youth (1625
years)
Original version
Factors: .72 to .84
EFA: Four factors
Positive correlation with global symptom
index (depression and anxiety) and alcohol
Sweden
Wiklander et al.,
2013
HSSC-8
4
58 HIV+ Child and
Adolescent (8-18 years
old)
Yes
Swedish
HSS-8: .81
Factors: .80 to .55
EFA: DC, NSI, CPA
9
Negative correlation with quality of life
related to the health (HRQoL)
Mozambique
(Ribáuè and
Malema)
Massicotte, 2010
HSS-40
5
237 HIV + ART
(HBC/non-HBC)
7
Portuguese and
Emakua
HSS-40: .97
Factors: .96 to .88
None
Negative correlation with quality of life
(Whoqol-Bref).
Fewer stigma in HBC that non-HBC.
1
HSS = HIV Stigma Scale;
2
HFSS = HIV Felt-Stigma Scale;
3
There is a translation to Amharic (Ethiopia) (Bezabhe et al., 2013);
4
HSSC = HIV Stigma Scale for Children;
5
HSS-40 (Berger et al., 2001) was also translated and back-translated into Bahasa Malaysia (Choi et al., 2010);
6
IQR=interquartile range;
7
ART= antiretroviral treatment;
HBC= Home Based Care program;
8
CFA=Confirmatory Factor Analysis;
9
Four Factors=Enacted Stigma, Disclosure Concerns (DC), Negative Self-Image (NSI), and
Concerns with Public Attitude (CPA);
10
EFA= Exploratory Factor Analysis;
11
Authors state it was field tested before use in Swahili but do not contribute any more
information.
Spanish adaptation of the HIV Stigma Scale 36
36
Appendix 2
Spanish adaptation of the HIV Stigma Scale
1
English
Spanish adaptation
4
Telling someone I have HIV is risky
1
Decirle a alguien que tienes el VIH es muy arriesgado
3
Peoples attitudes about HIV make me feel worse about myself
2
Las actitudes de la gente hacia el VIH me hacen sentir mal conmigo mismo
2
I feel guilty because I have HIV
3
Me siento culpable por tener el VIH
5
Most people with HIV lose their jobs when employers learn that they have HIV
4
Las personas seropositivas pierden su trabajo cuando sus jefes se enteran que tienen el VIH
6
I work hard to keep my HIV a secret
5
Me esfuerzo por mantener en secreto que tengo el VIH
7
I feel I am not as good as others because I have HIV
6
Siento que no soy tan bueno/a como el resto de la gente porque tengo el VIH
8
I am ashamed to tell other people that I have HIV
2
7
Me da vergüenza contarle a otras personas que tengo el VIH
2
9
People with HIV are treated like outcasts
8
Las personas con VIH son tratadas como marginadas
1
In many areas of my life, no one knows that I have HIV
9
En muchos ámbitos de mi vida nadie sabe que tengo el VIH
10
Many people believe that a person with HIV is despicable
2
10
Mucha gente cree que una persona con VIH es despreciable
2
-
I feel very anxious about transmitting HIV to other people
3
11
Me angustia transmitir a otras personas el VIH
3
12
I feel as if my body were dirty because I have HIV
2
12
Siento como si mi cuerpo estuviera sucio por tener el VIH
2
-
I would understand it if someone rejected my friendship because I have HIV
3
13
Entendería que alguien rechazara mi amistad porque tengo el VIH
3
-
Having HIV is a punishment for some of my behaviors
3
14
Tener el VIH es un castigo por algunos de mis comportamientos
3
16
Most people with HIV are rejected when others learn that they have HIV
15
Muchas personas son rechazadas cuando los demás se enteran que tiene el VIH
17
I am very careful who I tell that I have HIV
16
Tengo mucho cuidado a quien le digo que tengo el VIH
18
Some people who know that I have HIV have grown more distant
17
Alguna gente que conozco se ha vuelto más distante conmigo desde que saben que tengo VIH
-
I prefer to avoid having sexual relations because Im afraid of transmitting HIV to another
person
3
18
Prefiero evitar tener relaciones sexuales porque temo transmitir el VIH a la otra persona
3
20
Most people are uncomfortable around someone with HIV
19
La mayoría de la gente está incómoda si tiene cerca a alguien con VIH
21
I never felt that I have to hide the fact that I have HIV
20
Nunca he sentido la necesidad de esconder que tengo el VIH
22
I worry that people may judge me when they learn that I have HIV
21
Me preocupa que la gente me juzgue si se enteran de que tengo el VIH
24
I am hurt by how people react to learning I have HIV
22
Me siento herido/a por la manera en que la gente reacciona cuando sabe que tengo el VIH
25
I worry that people who know I have HIV will tell others
23
Me preocupa que la gente que sabe que tengo el VIH se lo cuente a otros
26
I regret having told some people that I have HIV
24
Me arrepiento de haberle dicho a algunas personas que tengo el VIH
29
People I care about stopped calling me after learning that I have HIV
25
Personas cercanas a mi han dejado de llamarme después de saber que tengo el VIH
32
People dont want me around their children once they know that I have HIV
26
Hay gente que no me deja estar cerca de sus hijos después de saber que tengo VIH
33
People have physically backed away from me because I have HIV
27
La gente se aparta físicamente de mi porque tengo el VIH
35
I have stopped socializing with some people due to their reactions
28
He dejado de relacionarme con algunas personas debido a sus reacciones
36
I have lost friends by telling them that I have HIV
29
He perdido buenos amigos/as por decirles que tengo el VIH
37
I told people close to me to keep my HIV a secret
30
Le he pedido a gente cercana a mí que guarde el secreto de que tengo el VIH
1
Item number of the original scale
2
Item with variations in the translation compared to the original item.
3
Item added based on the content analysis of the qualitative study
... There are many other factor analytic studies on persons with HIV using the original HSS with 40-item scales extracting four factors [10,17,[20][21][22][23]. Few other studies also found three factors [24,25]. ...
... Few other studies also found three factors [24,25]. There is only one study among HIV patients that reported higher order, bi-dimensional structures, named perceived external stigma and internalized stigma [22]. We also found a two-factor solution by exploratory factor analysis; however, a three-factor solution was reported by a similar study for the stigma of COVID-19. ...
... In our study, the CSS-M for COVID-19 appeared to show consistently high Cronbach's α ranging from 0.794 to 0.819, indicating good inter-item reliability, and the instrument's internal consistency. This was found to be in accordance with most of the recent studies [16,18,[21][22][23][24]26,27]. ...
Article
Full-text available
Background: The current coronavirus disease 2019 (COVID-19) pandemic has been found to be associated with increased psychosocial problems such as depression, anxiety, stress, and stigma. Many health-related stigma instruments that have been developed are condition-specific; these should be adapted and validated for generic use, across different health conditions. This study was conducted to measure stigma, stress, anxiety, and depression using the COVID-19 Stigma Scale-Modified (CSS-M), a modified version of the HIV Stigma Scale, among the Indian population. Methods: A weblink-based online survey was conducted using the adapted CSS-M, along with the Depression, Anxiety, and Stress Scale-21. Collected data were analyzed with correlation analysis, reliability analysis, exploratory factor analysis, and convergent and divergent validity. Results: With a sample size of 375, the modified scale for COVID-19 stigma showed internal consistency and a good inter-item correlation (Cronbach's alpha 0.821). Principal axis factoring with varimax rotation along with alternative parallel analysis established the two factorial structure and had valid composite reliability, discriminate validity, and partial convergent validity. Conclusion: We found that COVID-19 Stigma Scale-Modified is a valid measure to assess COVID-19-related stigma. The scale was found to be internally consistent with a good inter-item correlation, composite reliability, valid discriminate validity, and partial convergent validity. Specific COVID-related validated scales for stigma should be developed in the future.
... A score ≥8 points is strongly associated with anxiety or depression [38]. HIV-related stigma was evaluated by employing the Spanish version of the adapted HIV Stigma Scale [39], which includes 30 items, with a higher score indicating a greater perception of stigma. Patients' overall quality of life (QoL) was assessed using the fivelevel EQ-5D (EQ-5D-5L) [40,41]. ...
... The mean (SD) total UCLA-3 score was 3.98 points (1.70), and the median score (IQR) was 3 points [3][4][5]. In the case of SIL, the participants had a mean (SD) score of 34.3 (10.9) and a median (IQR) score of 36 [27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42] on the Lubben scale. ...
Article
Full-text available
Introduction There is a growing number of people with HIV who are aged 50 years or older, and the prevalence of loneliness and social isolation remains unknown. Methods A multicentre study was conducted across 22 GeSIDA centres. A survey was carried out to assess loneliness [UCLA 3‐item Loneliness Scale‐3 (UCLA‐3)] and social isolation [Lubben Social Network Scale‐Revised (LSNS‐R)], along with sociodemographic aspects, HIV‐related factors, comorbidities, tobacco, alcohol and drug consumption, quality of life, anxiety and depression, and stigma. The prevalence of loneliness (UCLA‐3 ≥ 6) and evident social isolation (LSNS‐R ≤ 20) was calculated, and multivariable multinominal logistic regression models were used to identify associated factors. Results A total of 399 people with HIV were included; 77.4% were men, of average age 59.9 years (SD 6.5); 45.1% were aged ≥60 years; 86% were born in Spain; 86.7% in urban areas; 56.4% with secondary or higher education; 4.5% living alone against their wishes. A total of 66.9% were infected through sexual transmission, with a median of 22.9 years since diagnosis [interquartile range (IQR): 12.6–29.5] and a median nadir CD4 count of 245 cells/μL (IQR: 89–440). Overall, 90.7% had viral load <50 copies/mL, 93.5% had adherence >95%, and 26.3% had a prior AIDS diagnosis. In all, 29.1% and 21% reported significant symptoms of anxiety and depression, respectively, 24.3% had mobility issues, and 40.8% reported pain. Overall, 77.7% of participants reported neither loneliness nor social isolation, 10.0% loneliness only, 5.8% social isolation only and 6.5% both. Multivariable analyses identified that being aged 50–59, unemployed or retired, living alone unwillingly, single, poor quality of life, anxiety, and HIV‐related stigma were associated with loneliness. Meanwhile, lower education, living alone unwillingly, and depressive symptoms were associated with social isolation. Individuals living alone unwillingly, with depressive symptoms and experiencing HIV‐related stigma were at higher risk for both loneliness and social isolation. Conclusions There is a relatively high prevalence of loneliness and social isolation in our population. Living alone against one's wishes, being unmarried, and experiencing mobility issues could predispose individuals to feel lonely and socially isolated. Those with anxiety and stigma are more prone to loneliness, while individuals with depression are more predisposed to social isolation. It is necessary to develop strategies for the detection and management of loneliness and social isolation in people with HIV aged >50 years.
... Characteristics of the included studies are shown in Appendix 3 Characteristics of the included studies. Study settings includes the US [26,27,29,[40][41][42][43][44][45][46][47][48][49][50], China [51][52][53][54][55][56][57], India [58][59][60][61][62], Spain [63][64][65], and South Africa [27,66,67]. With regard to study type, 40 were cross-sectional studies [26, 27, 29-32, 40-42, 44-46, 48-61, 64, 65, 67-77], two were cohort studies [66,78], two were case-control studies [43,62], and one was a randomized controlled trial [47]. ...
... No findings on measurement error or responsiveness were found in any of the 45 included studies. In structural validity, 12 studies were rated as "+" [29,30,32,46,60,63,65,67,68,70,71,78], five studies as "-" [40,51,55,57,76], and 22 studies were graded as "?" because they did not do it [26, 31, 43-45, 47-50, 52-54, 56, 58, 62, 64, 66, 69, 72-75]. In internal consistency, 31 studies were rated as "+" [26, 27, 30, 32, 40-42, 44, 47-49, 51, 52, 54, 56-59, 62-66, 68-70, 72, 74-76, 78], whereas 12 studies were rated as "-" [31,43,45,46,50,53,55,60,67,71,73,77]. ...
Article
Full-text available
Background The development of antiretroviral therapy broadly extends the life expectancy of persons living with HIV (PLHIV). However, stigma and discrimination are still great threat to these individuals and the world's public health care system. Accurate and reproducible measures are prerequisites for robust results. Therefore, it is essential to choose an acceptable measure with satisfactory psychometric properties to assess stigma and discrimination. There has been no systematic review of different stigma and discrimination tools in the field of HIV care. Researchers and clinical practitioners do not have a solid reference for selecting stigma and discrimination measurement tools. Methods We systematically searched English and Chinese databases, including PubMed, EMBASE, CINAHL, Web of Science, PsycINFO, ProQuest Dissertations and Theses, The Cochrane Library, CNKI,, and Wanfang, to obtain literature about stigma and discrimination measurement tools that have been developed and applied in the field of HIV. The search period was from 1st January, 1996 to 22nd November 2021. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) guideline (2018 version) was applied to assess the risk of bias for each involved study and summarize the psychometric properties of each tool. The modified version of the Grading of Recommendations Assessment, Development, and, Evaluation (GRADE) method was used to grade the evidence and develop recommendations. Results We included 45 studies and 19 PROMs for HIV/AIDS-related stigma and discrimination among PLHIV. All studies had sufficient methodological quality in content validity, structural validity, internal consistency, and the hypothesis testing of structural validity. Limited evidence was found for cross-cultural validity, stability, and criterion validity. No relevant evidence was found concerning measurement error and responsiveness. The Internalized AIDS-related Stigma Scale (IARSS), Internalized HIV Stigma Scale (IHSS), and Wright's HIV stigma scale (WHSS) are recommended for use. Conclusions This study recommends three PROMs for different stigma and discrimination scenarios, including IARSS for its good quality and convenience, IHSS for its broader range of items, higher sensitivity, and greater precision, and WHSS for its comprehensive and quick screening. Researchers should also consider the relevance and feasibility of the measurements before putting them into practice. Systematic review registration PROSPERO CRD42022308579
... Unlike standard tools and clinical interviews that may require multiple assessments and considerable time, the CST-HIV offers an efficient and targeted way to identify the most pressing HRQoL concerns in clinical practice. PHIV in Spain commonly report high levels of psychological distress, sleep/fatigue and social support deficiencies [13,[31][32][33][34][35][36]. These findings highlight the critical need for effective screening and intervention strategies to address these pervasive issues. ...
Article
Full-text available
Objectives The objective is to assess the interconnectedness of a network of health‐related quality of life (HRQoL) variables among people with HIV (PHIV) to identify key areas for which clinical interventions could improve HRQoL for this population. Methods Between 2021 and 2023, we carried out a cross‐sectional study within the Spanish CoRIS cohort. We conducted a weighted and undirected network analysis, which examines complex patterns of relationships and interconnections between variables, to assess a network of eight HRQoL dimensions from the validated Clinic Screening Tool for HIV (CST‐HIV): anticipated stigma, psychological distress, sexuality, social support, material deprivation, sleep and fatigue, cognitive problems and physical symptoms. Results A total of 347 participants, predominantly male (93.1%), currently working (79.0%), self‐reported homosexual (72.6%) and college‐educated (53.9%), were included in the study. Psychological distress showed the highest centrality in the network, indicating its strong connections with sleep and fatigue, cognitive problems and social support within the HRQoL network. Conclusions Psychological distress, sleep and fatigue, cognitive issues and social support were identified as key factors in an HRQoL network, indicating that interventions focused on these areas could significantly enhance overall well‐being.
... Realizou-se a análise da consistência interna das subescalas, apresentando excelente confiabilidade. O modelo como os itens foram carregados é consistente com dois mecanismos de estigma presentes em outras escalas de avaliação de estigmatização relacionadas a processos patológicos: estigma personalizado ou internalizado e o estigma promulgado, que abrange as experiências negativas de um indivíduo com outras pessoas(Earnshaw, et al. 2013;Fuster-Ruizdeapodaca, et al. 2015). Destaca-se que os itens 6 e 7 não carregaram em um único fator, refletindo as preocupações diante das atitudes da população e seus impactos.A EAE-COVID-19 pode mensurar adequadamente essas duas dimensões do estigma relacionado à Covid-19, apresentando o potencial de fornecer informações importantes do ponto de vista psicossocial da população em pesquisa. ...
Article
O estigma é um processo social associado às relações de poder, apoiado em raízes histórico-culturais. Pode ser consequente de vários fatores, como nas relações de gênero e as alterações do estado de saúde, como na pandemia por Covid-19. Diante deste cenário, objetivou-se avaliar as propriedades psicométricas de uma escala adaptada para estimar o estigma em mulheres que contraíram a Covid-19. Trata-se de um estudo transversal de prevalência, com abordagem quantitativa, de base populacional, no qual foram entrevistadas (n=228) mulheres que testaram positivo após terem sido notificadas por apresentarem sintomas da Covid-19. As participantes foram caracterizadas quanto às condições socioeconômicas e demográficas. Foi utilizada uma adaptação da escala de estigma quanto a hanseníase, que visa obter informações acerca da ocorrência do processo de estigmatização em decorrência da Covid-19. Aplicaram-se os testes de confiabilidade (consistência interna/Alfa de Cronbach e reprodutibilidade/Kappa) e, somado a isso, foi realizada a Análise Fatorial Exploratória. As medidas do coeficiente de Alfa de Cronbach dos 18 itens da escala variam entre (0,81-0,90) e do coeficiente de Kappa entre (0,72-0,87). Foram realizados os testes de Kaiser-Meyer-Olkin (0,85) e de Esfericidade de Bartlett (significância de 0,000). As pontuações da escala variaram de 10 a 55 pontos e a média do escore final apresentado pelas participantes foi de 43,6, com escores mais altos representando maiores níveis de estigma e pontuações mais baixas menores índices. Nenhuma das participantes esteve isentas de algum grau potencial de estigmatização. A escala EAE-COVID-19 apresenta propriedades psicométricas satisfatórias, permitindo mensurar adequadamente as dimensões do estigma relacionado à Covid-19.
... Based on previous studies conducted in Spain [21][22][23], we estimated that a sample of 500 people with HIV would be adequate to achieve the objectives of the study while ensuring the representativeness of the sample and considering that it is not possible to perform probability sampling in an anonymous study with patients with HIV. However, for further assurance, we calculated the a priori sample size needed for the comparison of mean differences with two independent groups with the Gpower program, which found that a sample of 210 people with HIV would obtain a power of 0.95. ...
Article
Full-text available
Objectives We aimed to assess HIV symptoms from the perspective of both patients and HIV specialists and the impact of discontinuing antiretroviral treatment (ART) on symptomology. We gathered opinions from HIV specialists and people living with HIV about ideal ART parameters and treatment satisfaction. Methods Ex post‐facto cross‐sectional surveys were administered to 502 people living with HIV and 101 HIV clinicians in Spain (18 sites). Results The median age of participants with HIV was 43.2 years, 74.5% were male, and 91.6% had an undetectable viral load. The mean time since initiation of ART was 10.2 years. Between 54% and 67% of people living with HIV reported experiencing nervousness or anxiety, sadness, fatigue, sleep problems, or muscle/joint pain during the preceding 4 weeks. However, only 22%–27% of specialists acknowledged the presence of these symptoms. The most bothersome symptoms were related to mental health or the central nervous system. There were significant differences between the burden of symptoms reported by people living with HIV and those acknowledged by specialists. The symptoms that more frequently caused ART discontinuation were depression, dizziness, and sleep problems. Both people living with HIV and specialists prioritized ART efficacy and low toxicity, but their importance ratings differed for 5 of the 11 ART characteristics assessed. People living with HIV rated their satisfaction with ART at a mean (± standard deviation) of 8.9 ± 1.5 out of 10, whereas HIV specialists rated it lower, at 8.3 ± 0.7 (p < 0.001). Conclusions Despite advances in HIV care and treatment, a large proportion of patients still experience symptoms. HIV specialists may not be fully aware of these. People living with HIV and HIV specialists are, overall, satisfied with ART. However, the importance they place on different ART characteristics may vary.
... As another author suggested, other factors such as depression or gay community attachment could be mediating the association between internalized homophobia and drug use and therefore, should also be explored (Moody et al., 2018). Participants living with HIV in both groups also showed similar scores on the HIV Stigma Scale (55.6 (12.3) vs. 58.7 (13.2)), both lower than those published in the Spanish normative data (77.7 (17)) (Fuster-RuizdeApodaca et al., 2015). The last finding may be due to the fact that the normative sample included other people living with HIV than only GBMSM. ...
Article
Full-text available
Background: Although evidence shows that engaging in chemsex can be associated with poor mental health, little is known about the relationship between psychological factors and this type of drug use. We aim to explore associations between engagement in chemsex and several psychological variables (adverse life events, attachment styles, emotional regulation skills, self-care patterns) in a sample of gay, bisexual, and other men who have sex with men (GBMSM) with drug-related problems. Methods: A group of GBMSM engaged in chemsex (n = 41) and a control group of GBMSM (n = 39) completed an online survey to assess drug-related problems and the abovementioned psychological variables, in which both groups were compared. All analyses were adjusted for covariates showing significant differences between groups. Results: Compared to the control group, participants engaged in chemsex showed significantly higher frequencies of an avoidant-insecure attachment style and early adverse life events, regardless of all covariates (HIV status, job situation, and place of birth). Poorer emotional regulation and self-care patterns and a higher frequency of sexual abuse were also found in participants engaged in chemsex, though we cannot rule out the influence of HIV status on this second group of variables. Conclusions: Some people with drug-related problems engaged in chemsex might have suffered early adverse events and might have an avoidant-insecure attachment style. Moreover, those who have been diagnosed with HIV might show higher emotional dysregulation and poorer self-care patterns. These variables should be routinely evaluated in this population.
Article
Full-text available
Background The Ryan White Medical Case Management System, which serves more than half of people living with HIV (PLWH) in the USA, is an opportune setting for identifying and addressing depression among PLWH. A growing body of research suggests that interventions that promote positive emotion may lessen symptoms of depression and improve physical and psychological well-being among people experiencing a variety of health-related stress, including living with HIV. Research on how best to integrate standardized mental health screening and referral to evidence-based interventions in Ryan White Medical Case Management settings has the potential to improve the health and wellbeing of PLWH. Methods This mixed-methods study will enroll up to N = 300 Ryan White clients who screen positive for depressive symptoms in ORCHID (Optimizing Resilience and Coping with HIV through Internet Delivery), a web-based, self-guided positive emotion regulation intervention. The study will be conducted in 16 Ryan White Medical Case Management clinics in Chicago, IL. Following pre-implementation surveys and interviews with Medical Case Managers (MCMs) and Supervisors to develop an implementation facilitation strategy, we will conduct a hybrid type 2 implementation-effectiveness stepped wedge cluster randomized trial to iteratively improve the screening and referral process via interviews with MCMs in each wedge. We will test the effectiveness of ORCHID on depression and HIV care outcomes for PLWH enrolled in the program. RE-AIM is the implementation outcomes framework and the Consolidated Framework for Implementation Research is the implementation determinants framework. Discussion Study findings have the potential to improve mental health and substance use screening of Ryan White clients, decrease depression and improve HIV care outcomes, and inform the implementation of other evidence-based interventions in the Ryan White Medical Case Management System. Trial registration ClinicalTrials.gov NCT05123144. Trial registered 6/24/2021
Article
Spain was close to meeting the 90-90-90-treatment target set by UNAIDS. However, data on health care quality regarding people with HIV and their health-related quality of life (HRQoL) after the COVID-19 pandemic onset is scarce. By considering the perspective of people with HIV and HIV specialists, we aimed to determine some aspects of the quality of care in Spain, such as access to health resources or satisfaction with primary and speciality care, and assess people with HIV health-related quality of life. Ex post facto cross-sectional surveys were administered to 502 people with HIV and 101 HIV clinicians. Unmet needs related to healthcare system and healthcare resources access and to antiretroviral treatment administered by hospital pharmacies were detected. There was also room for improvement in the primary care service delivery and in various aspects concerning people's with HIV HRQoL. About one-fourth of them experienced stigmatisation in the healthcare setting, which was significantly related to HRQoL. Women, heterosexual participants and those with problems accessing the healthcare system scored poorer in the HRQoL scales. Moreover, according to our data, HIV specialists did not seem to be fully aware of patients' with HIV needs and overestimated their HRQoL.
Article
Full-text available
Background: The management of people living with HIV/AIDS (PLWHA) is multidimensional and complex. Using patient-reported outcome measures (PROMs) has been increasingly recognized to be the key factor for providing patient-centered healthcare to meet the lifelong needs of PLWHA from diagnosis to death. However, there is currently no consensus on a PROM recommended for healthcare providers and researchers to assess health outcomes in PLWHA. Objective: The purpose of this systematic review was to summarize and categorize the available validated HIV-specific PROMs in adult PLWHA and to assess these PROMs using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) methodology. Methods: This systematic review followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Literature search of three recommended databases (PubMed, Embase, and PsychINFO) was conducted on January 15, 2021. Studies were included if they assessed any psychometric property of HIV-specific PROMs in adult PLWHA and met the eligibility criteria. The PROMs were assessed for nine psychometric properties, evaluated in each included study following the COSMIN methodology by assessing the following: (1) the methodological quality assessed using the COSMIN risk of bias checklist, (2) overall rating of results, (3) level of evidence assessed using the modified Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, and (4) level of recommendation. Results: A total of 88 PROMs classified into eight categories, assessing the psychometric properties of PROMs for adult PLWHA, were identified in 152 studies including 79213 PLWHA. The psychometric properties of the majority of the included PROMs were rated with insufficient evidence. The PROMs that received Class A recommendation were the Poz Quality of Life, HIV Symptom Index or Symptoms Distress Module of the ACTG, and the People Living with HIV Resilience Scale. In addition, because of lack of evidence, recommendations regarding use could not be made for most of the remaining assessed PROMs (received class B recommendation). Conclusions: This systematic review recommends three PROMs to assess health outcomes in adult PLWHA. However, all these PROMs have some shortcomings. In addition, most of the included PROMs do not have sufficient evidence for assessing their psychometric properties, and require a more comprehensive validation of the psychometric properties in the future to provide more scientific evidence. Thus our findings may provide a reference to the selection of high-quality HIV-specific PROMs by healthcare providers and researchers for clinical practice and research. Clinicaltrial:
Article
Full-text available
The goal of this study was to assess an intervention program to reduce the impact of stigma on people with HIV and to enable them to cope with it. A quasi-experimental design, with non-equivalent control group and pre- and posttest was used. Participants were 221 people with HIV, of whom 164 received the intervention and 56 made up the non-equivalent control groups. The dependent variables were perception of stigma—enacted and internalized—, self-esteem, perception of self-efficacy, strategies used to cope with stigma—primary control, secondary control, and avoidance—and quality of life. Analysis of variance (MANOVAS and ANOVAS) was conducted to determine pretest differences and differential scores in both groups, and analysis of covariance (MANCOVAS and ANCOVAS) was performed to assess the efficacy of the program. The results showed reduction of perceived stigma and avoidance strategies and an increase in perceived self-efficacy to cope with stigma, disposition to use approach strategies, self-esteem, and quality of life. These results indicate that it is possible to train people with HIV to cope with stigma.
Article
Full-text available
To analyze the temporal evolution of HIV-related stigma in Spain between 2008 and 2012. We interviewed a representative sample of the Spanish population (N = 1619) through computer-assisted telephone interviews. The survey measures diverse facets of stigma and other-related variables. We compared the data of the 2012 survey with the result of the survey carried out in 2008. The degree of discomfort concerning people with HIV decreased significantly in 2012. Avoidance intention, negative feelings, the number of people who agreed with the implementation of harsh discriminatory policies, and the number of people who blame people with HIV were also lower in 2012. However, there are still misconceptions about HIV transmission. Attitudes of the Spanish population toward people with HIV have improved in the last four years. However, some attitudes and beliefs still need to be changed.
Article
Full-text available
HIV is a stigmatizing medical condition. The concept of HIV stigma is multifaceted, with personalized stigma (perceived stigmatizing consequences of others knowing of their HIV status), disclosure concerns, negative self-image, and concerns with public attitudes described as core aspects of stigma for individuals with HIV infection. There is limited research on HIV stigma in children. The aim of this study was to test a short version of the 40-item HIV Stigma Scale (HSS-40), adapted for 8--18 years old children with HIV infection living in Sweden. A Swedish version of the HSS-40 was adapted for children by an expert panel and evaluated by think aloud interviews. A preliminary short version with twelve items covering the four dimensions of stigma in the HSS-40 was tested. The psychometric evaluation included inspection of missing values, principal component analysis (PCA), internal consistency, and correlations with measures of health-related quality of life (HRQoL). Fifty-eight children, representing 71% of all children with HIV infection in Sweden meeting the inclusion criteria, completed the 12-item questionnaire. Four items concerning participants' experiences of others' reactions to their HIV had unacceptable rates of missing values and were therefore excluded. The remaining items constituted an 8-item scale, the HIV Stigma Scale for Children (HSSC-8), measuring HIV-related disclosure concerns, negative self-image, and concerns with public attitudes. Evidence for internal validity was supported by a PCA, suggesting a three factor solution with all items loading on the same subscales as in the original HSS-40. The scale demonstrated acceptable internal consistency, with exception for the disclosure concerns subscale. Evidence for external validity was supported in correlational analyses with measures of HRQoL, where higher levels of stigma correlated with poorer HRQoL. The results suggest feasibility, reliability, as well as internal and external validity of the HSSC-8, an HIV stigma scale for children with HIV infection, measuring disclosure concerns, negative self-image, and concerns with public attitudes. The present study shows that different aspects of HIV stigma can be assessed among children with HIV in the age group 8--18.
Article
Full-text available
Achievement of optimal medication adherence and management of antiretroviral toxicity pose great challenges among Ethiopian patients with HIV/AIDS. There is currently a lack of long-term follow-up studies that identify the barriers to, and facilitators of, adherence to antiretroviral therapy (ART) in the Ethiopian setting. Therefore, we aim to investigate the level of adherence to ART and a wide range of potential influencing factors, including adverse drug reactions occurring with ART. We are conducting a 1-year prospective cohort study involving adult patients with HIV/AIDS starting on ART between December 2012 and March 2013. Data are being collected on patients' appointment dates in the ART clinics. Adherence to ART is being measured using pill count, medication possession ratio and patient's self-report. The primary outcome of the study will be the proportion of patients who are adherent to their ART regimen at 3, 6 and 12 months using pill count. Taking 95% or more of the dispensed ART regimen using pill count at given points of time will be considered the optimal level of adherence in this study. Data will be analysed using descriptive and inferential statistical procedures. Ethics approval was obtained from the Tasmania Health and Medical Human Research Ethics Committee and Bahir-Dar University's Ethics Committee. The results of the study will be reported in peer-reviewed scientific journals, conferences and seminar presentations.
Article
It has been 50 years since the publication of Goffman's influential work Stigma: Notes on the Management of Spoiled Identity. This special issue celebrates Goffman's contribution with 14 articles reflecting the current state of the art in stigma research. In this article, we provide a theoretical overview of the stigma concept and offer a useful taxonomy of four types of stigma (public stigma, self-stigma, stigma by association, and structural stigma). We utilize this taxonomy to organize an overview of the articles included in this special issue. Finally, we outline new developments and challenges in stigma research for the coming decades.
Chapter
Stigma is a historical and social phenomenon that has influenced a variety of aspects of human life. Particular diseases, such as leprosy, human immunodeficiency virus and acquired immunodeficiency syndrome (HIV and AIDS), and epilepsy among others, are typical examples of diseases affected by stigma. A variety of reports have shown strong and significant rates of stigma against people with these diseases by the general population and even by their families and health workers in different societies. Resulting deterioration in the mental health, such as depression, anxiety and somatic symptoms, of these people has also been reported. Pioneering studies have revealed that quality of life (QOL) is most significantly lowered by the presence of perceived stigma, which represents the internal belief of affected people that they are being stigmatized, rather than the actual stigmatic beliefs and behaviors rendered by others. Previous efforts of international communities such as United Nations (UN) systems, non-governmental organizations (NGOs) and other stakeholders have mainly been aimed at decreasing the prevalence and incidence of such diseases. However, it is imperative to pay sufficient attention to the QOL and stigmatization of people with these diseases in terms of their human rights, dignity, and physical, mental and social well-being. Integrating perspectives on stigma and QOL among people who are living with diseases susceptible to stigmatization into existing internationally prioritized development strategies, policies and programs, e.g., Millennium Development Goals (MDGs), with long-term perspectives is important. Further empirical studies on this issue and implementation and evaluation of the strategies, policies and programs are warranted.
Article
Using a community sample of 197 people living with HIV/AIDS, we examined how awareness of societal stigma (felt stigma) and negative feelings toward oneself as a member of a stigmatized group (self-stigma) are related to psychological well-being. Both felt stigma and self-stigma were significantly correlated with symptoms of depression and anxiety, but controlling for felt stigma reduced self-stigma's association with depressive symptoms to nonsignificance. Global self-esteem and social avoidance fully mediated the associations between self-stigma and distress but only partially mediated the associations between felt stigma and distress. Felt stigma mediated the relationship between distress and HIV-related changes in physical appearance.
Book
DefinitionA test of the formed elements of the blood – red cells, hemoglobin, white cells and platelets.
Article
Developed by the International Test Commission, the International Guidelines on Computer-Based and Internet-Delivered Testing are a set of guidelines specifically developed to highlight good practice issues in relation to computer/Internet tests and testing. These guidelines have been developed from an international perspective and are directed at various stakeholders in the testing process. Although specifically structured under headings of test developers, test publishers, and test users, the guidelines are a useful reference for other stakeholders in the testing process. The guidelines address 4 main issues identified as key areas to ensure good practice in computer/Internet testing: technological issues, quality issues, control issues, and security issues. These 4 issues are considered high-level issues and are further broken down into second-level specific guidelines. A third-level set of accompanying examples is provided to the relevant stakeholder mentioned previously.